Can this document be signed electronically?

Yes. Under the federal ESIGN Act (15 U.S.C. ch. 96) and UETA, electronic signatures are legally valid for most research documents when intent, consent, attribution, and retention can be demonstrated. Exceptions include wills and certain court filings.

What makes an e-signature valid?

A legally valid e-signature generally meets four criteria: (1) intent to sign, (2) consent to transact electronically, (3) attribution to the signer, and (4) retention that reproduces the record. Maintain audit trails and authentication logs as evidence.

Are there HIPAA considerations for signed documents?

If the document contains protected health information, HIPAA applies. Use a business associate agreement with vendors, ensure encryption and access controls, and retain records for six years per 45 CFR §164.530(j).

How should signer identity be verified?

Common methods include email confirmation, SMS one-time codes, knowledge-based checks, SSO, and stronger identity proofing for high-risk studies. Document the chosen authentication approach in the protocol for IRB review.

Can minors consent electronically?

Minors typically cannot provide legally effective consent alone. Obtain parental or guardian consent and assent from the minor when required; IRB policies and state laws determine age thresholds and additional protections.

Why was my submission rejected by IRB or sponsor?

Common reasons include missing signature pages or dates, mismatched signer names, incomplete mandatory fields, unsigned consent materials, or lack of required data protection language. Review the audit trail, correct deficiencies, and resubmit with explanations.

Electronic Signature
Templates
Miscellaneous
Research Science Document

Research Science Document

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

RESEARCH SCIENCE DOCUMENT

Project Title:

Sponsor / Funding Entity Research Organization / Institution Principal Investigator

RECITALS

WHEREAS, Sponsor desires to retain the Research Organization to perform scientific and technical research services described in this Document to advance the objectives of the Project; and

WHEREAS, Research Organization represents that it possesses the personnel, facilities and expertise necessary to perform the research and agrees to perform such research under the terms set forth herein.

WHEREAS, the parties intend that this Document govern the scope, deliverables, schedule, compensation and the handling of confidential information and intellectual property arising from the Project.

SCOPE OF WORK

Research Organization shall perform the research activities, experiments and analysis described below and in any attached schedules. The parties agree that the Scope may be amended only by written change order signed by authorized representatives of both parties.

Detailed Scope of Work Key Deliverables and Acceptance Criteria

PAYMENT TERMS

Sponsor will pay Research Organization the compensation set forth below in consideration for the performance of the Scope of Work. Payments shall be conditioned on timely delivery of invoices and, where applicable, acceptance of deliverables as set forth above.

Total Funding Amount (USD) Payment Schedule (milestones, amounts, and timing) Late Payment Fee

TERM AND TERMINATION

This Document commences on the Start Date and continues until the Completion Date unless earlier terminated in accordance with this section.

Start Date: Completion Date:

Termination Notice Period

Either party may terminate this Document for material breach by the other party if the breach is not cured within the notice period specified above. Sponsor may suspend funding immediately for activities that pose an imminent safety risk or otherwise violate applicable law or regulations.

CONFIDENTIALITY

Each party shall hold in confidence any confidential information disclosed by the other party and shall not disclose such information to third parties except to employees, contractors or collaborators who have a need to know and are bound by confidentiality obligations at least as protective as those herein. Confidential information does not include information that is or becomes publicly known without breach of this Document, is rightfully obtained from a third party, or is independently developed.

Confidentiality Acknowledgment

Research Organization acknowledges that Sponsor may provide confidential or proprietary materials and agrees to protect such materials in accordance with this Document.

INTELLECTUAL PROPERTY AND PUBLICATION

Unless otherwise agreed in a separate signed agreement, Background Intellectual Property of each party remains the property of that party. Intellectual property conceived or reduced to practice in the performance of the Project (Project IP) shall be owned as follows: Research Organization shall own Project IP, subject to a non-exclusive, royalty-free license to Sponsor to use results for internal research and evaluation purposes. The parties shall negotiate commercialization rights in good faith. Research Organization shall provide Sponsor with a prior written review period of publications that disclose Sponsor Confidential Information, not to exceed 45 days.

COMPLIANCE; WARRANTIES; LIMITATION OF LIABILITY

Research Organization warrants that services will be performed in a professional manner in accordance with generally accepted scientific standards. Each party shall comply with applicable laws, regulations and institutional policies, including those governing the protection of human subjects, animals and hazardous materials. Except for the foregoing warranty and willful misconduct or gross negligence, neither party makes other warranties and liability for direct damages shall be limited to amounts paid under this Document during the twelve months preceding the claim. Neither party shall be liable for consequential, incidental or punitive damages.

GOVERNING LAW

This Document shall be governed by and construed in accordance with the laws of: , without regard to its conflict of law principles.

ENTIRE AGREEMENT

This Document, together with any exhibits or schedules expressly incorporated, constitutes the entire agreement between the parties with respect to the subject matter and supersedes all prior or contemporaneous agreements, understandings and communications, whether written or oral. Any amendment or modification must be in writing and signed by authorized representatives of both parties.

NOTICES

Sponsor Notice Address Research Organization Notice Address

Sponsor (Printed Name):

By (Signature):

Date:

Research Organization (Printed Name):

By (Signature):

Date:

What the Research Science Document Is and what it covers

The Research Science Document is a formal record used to describe study design, methods, data handling, and participant protections for a research project conducted in the United States. It typically includes objectives, hypotheses, inclusion and exclusion criteria, protocols for data collection and analysis, consent materials, and plans for data storage and sharing. The document serves as the primary reference for institutional review boards, sponsors, collaborators, and auditors, and is used to demonstrate regulatory compliance, reproducibility, and ethical oversight throughout the study lifecycle.

Why a clear Research Science Document matters

A clear Research Science Document centralizes study decisions, reduces misunderstandings, and supports IRB review, audit readiness, and sponsor reporting. It clarifies roles, standardizes procedures, and documents data protections required by federal rules such as ESIGN for electronic records and HIPAA for health data.

Who typically prepares and relies on this document

Primary users include principal investigators, research coordinators, IRB administrators, data managers, and sponsor representatives involved in study governance.

Academic investigators and lab leads managing protocol design and IRB submissions.
Clinical research coordinators handling enrollment, consent documentation, and data capture.
Sponsors, contract research organizations, and regulatory affairs staff reviewing compliance and reporting.

Use this document to align stakeholders, support training, and maintain an auditable record of study procedures.

Core sections every Research Science Document should include

Core sections define purpose, methodology, participant protections, data management, analysis plans, and version control to ensure reproducibility and regulatory compliance.

Title and Scope

Include study title, short description, objectives, primary and secondary endpoints, target population, and study phase. Keep scope precise to prevent scope creep and to guide IRB evaluation and consent language.

Methodology

Detail study design, randomization, blinding, sample size calculation, statistical methods, intervention procedures, and data collection instruments. Specify any adaptive elements and monitoring plans for protocol deviations.

Inclusion/Exclusion

List precise inclusion and exclusion criteria to support reproducible enrollment and justify subgroup analyses. Note any special populations and explain risk mitigation measures for vulnerable participants.

Consent Materials

Provide full informed consent text, assent forms for minors, recruiter scripts, and a description of how consent will be documented electronically or in writing consistent with ESIGN and institutional requirements.

Data Management

Describe data collection forms, coding standards, de-identification procedures, storage location, backup schedule, access controls, and retention policies aligned with HIPAA and institutional policies.

Version Control

Record version number, effective date, and change log for protocol amendments. Ensure distribution lists and training records reflect the active protocol version.

Stepwise process to prepare and finalize the Research Science Document

Follow this sequence to prepare, approve, and archive the Research Science Document for regulatory compliance and reproducibility.

01

Draft Document: Assemble protocol, methods, and consent materials.
02

Internal Review: Circulate to co-investigators and statistician for feedback.
03

IRB Submission: Prepare application, attachments, and disclosures for review.
04

Finalize & Archive: Record signatures, log version, and store master copy.

How electronic execution streamlines approvals

Electronic completion streamlines approvals by combining form filling, identity checks, signatures, and secure storage into one auditable workflow.

Upload Document: Start with a PDF or DOCX master file.
Place Fields: Add signature, date, and conditional fields where needed.
Authenticate: Choose email, SMS, or advanced methods per policy.
Complete Audit: Capture timestamps, IPs, and completion certificates.

Field	Configuration
Signer Authentication	Email OTP or SSO per institutional policy.
Signature Order	Sequential signing to capture approvals in order.
Conditional Fields	Show sections only for applicable study arms.
Archive Location	Secure repository with access controls and retention.

Platform capabilities to check before e-submission

Ensure the chosen platform supports secure signatures, audit trails, and data export formats compatible with institutional repositories and review boards.

File Formats: PDF/A, PDF, and DOCX supported.
Integrations: Connects with NetSuite, Salesforce, Box, Google Workspace.
Access Controls: Role-based access and SSO.

Typical submission and reporting timelines to track

Key submission and reporting deadlines for research projects, including IRB, registry, and sponsor milestones, are critical to maintain compliance.

IRB Initial Submission:

Allow four to eight weeks for review by IRB.

Amendment Review:

Submit amendments promptly; expect two to four week review timelines.

ClinicalTrials.gov:

Register applicable interventional studies within 21 days of first participant enrollment.

Annual Progress:

Provide annual progress reports to IRB and sponsor per protocol.

Data Retention Start:

Retention obligations begin on effective date or final report date.

Consequences and common risks of incomplete or incorrect documents

IRB Noncompliance: Suspension of study activities.

HIPAA Violation: Civil penalties and corrective plans.

Data Loss: Loss of funding and reputational harm.

Incorrect Consent: Invalidated participant data.

Missing Registry: Possible sponsor fines.

Wrong Signature: Regulatory records may be rejected.

Entry pricing and feature comparison for common eSignature vendors

Compare typical entry-level pricing and core features for common eSignature vendors relevant to executing research documents and consent forms.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day free trial	Varies by vendor	Varies by vendor	Varies by vendor	Varies by vendor
Bulk Send	Yes	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No
Envelope Cap	No envelope cap	100 envelopes/user/year	Varies by plan	Varies by plan	Varies by plan

FAQs and troubleshooting for preparing and e-signing your document

Answers to common legal, technical, and procedural questions about completing, signing, and preserving the Research Science Document.

Need help? Contact support

Can this document be signed electronically?
Yes. Under the federal ESIGN Act (15 U.S.C. ch. 96) and UETA, electronic signatures are legally valid for most research documents when intent, consent, attribution, and retention can be demonstrated. Exceptions include wills and certain court filings.
What makes an e-signature valid?
A legally valid e-signature generally meets four criteria: (1) intent to sign, (2) consent to transact electronically, (3) attribution to the signer, and (4) retention that reproduces the record. Maintain audit trails and authentication logs as evidence.
Are there HIPAA considerations for signed documents?
If the document contains protected health information, HIPAA applies. Use a business associate agreement with vendors, ensure encryption and access controls, and retain records for six years per 45 CFR §164.530(j).
How should signer identity be verified?
Common methods include email confirmation, SMS one-time codes, knowledge-based checks, SSO, and stronger identity proofing for high-risk studies. Document the chosen authentication approach in the protocol for IRB review.
Can minors consent electronically?
Minors typically cannot provide legally effective consent alone. Obtain parental or guardian consent and assent from the minor when required; IRB policies and state laws determine age thresholds and additional protections.
Why was my submission rejected by IRB or sponsor?
Common reasons include missing signature pages or dates, mismatched signer names, incomplete mandatory fields, unsigned consent materials, or lack of required data protection language. Review the audit trail, correct deficiencies, and resubmit with explanations.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now